MODERNA LAUNCHES MRNA BIRD FLU TRIAL FOR CHICKENS AFTER HHS OFFSETS FUNDING TO BUY 4,000 DECORATIVE SWORDS
By Quinton Drabwhistle, MD (Unaffiliated Dental Pavilion) — Wed, 22 Apr 2026 04:06:24 GMT
The pharmaceutical giant plans to inject millions of poultry with 'computational hope' as federal funds are diverted to the Pentagon’s new Medieval Combat Readiness program.
""Our data suggests that while the vaccine doesn't stop the spread, it does make the chickens feel like they're in a high-intensity Pilates class," said Dr. Vaneer Squelch, Senior Vice President of Avian Aspirations." — KEY SLUDGE FINDING
Moderna scientists announced Wednesday that they are moving forward with a massive mRNA bird flu vaccine trial despite the Department of Health and Human Services (HHS) pulling its financial support. The federal agency reportedly emptied its 'Pandemic Preparedness' coffers last Tuesday to facilitate the emergency procurement of 4,000 decorative broadswords for the Pentagon’s new Office of Historical Intimidation.
The trial, dubbed 'Operation Cluck-and-Cover,' aims to deliver synthetic genetic instructions directly into the wing-meat of US poultry. According to internal documents, the goal is to teach chicken immune systems to recognize the H5N1 virus as a 'clueless intern who doesn't belong in the boardroom.' Without federal grants, Moderna has turned to a subscription model, asking local farmers to pay a monthly 'Feather-Shield' premium in exchange for bi-weekly misting sessions.
Dr. Vaneer Squelch, Senior Vice President of Avian Aspirations at Moderna, stood before a crowd of confused egg-producers to explain the science. "We aren't just giving them a vaccine; we are giving them a vibe-check for their cellular receptors," Squelch shouted over the sound of a nearby tractor. "By utilizing the same mRNA platform that sparked a billion Thanksgiving arguments, we can ensure that our chickens are not just healthy, but fundamentally disrupt the very concept of illness. If a chicken believes it is healthy, is the virus even real? That is the question we are charging $400 per dose to answer."
Critics of the move, including the National Association of Concerned Omelet Enthusiasts, have raised concerns about the long-term effects of mRNA on nugget texture. There are unconfirmed reports from the first test batch in Delaware that vaccinated roosters have begun crowing in a more 'melodic, synthesised tone' and refuse to peck at anything that isn't organic kale. Moderna has dismissed these claims as 'anecdotal poultry-propaganda' spread by big-pharma skeptics who haven't read the 4,000-page white paper.
Meanwhile, the HHS defended its decision to pivot funding toward the decorative sword initiative. A spokesperson clarified that a 'well-armed infantry of bureaucrats' is a more cost-effective deterrent against viral pathogens than 'fancy science juice.' The swords, which feature mahogany hilts and are strictly for 'wall-mounting purposes,' are expected to boost employee morale at the CDC by at least 4% during the next outbreak.
As the trial enters Phase III, Moderna is looking for 10,000 volunteer hens who are 'career-driven and not afraid of a little bit of genetic refactoring.' Interested farmers are encouraged to upload their flock's LinkedIn profiles to the Moderna portal. The company hopes to have a retail version of the vaccine available by autumn, tentatively titled 'I Can't Believe It's Not Immunity.'